Skip to Main Content

Advertisement

Skip Nav Destination

Abstract LB003: Fragment based discovery of MRTX9768, a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors

Cancer Res (2021) 81 (13_Supplement): LB003.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Kewei Chang
  • Dan Gao
  • Jidong Yan
  • Liyan Lin
  • Tingting Cui
  • Shemin Lu
Molecular Neurobiology (2023) 60 (10): 6060.
  • Chaohua Guo
  • Lintao Wu
  • Xumei Zheng
  • Lin Zhao
  • Xiaojia Hou
  • Zhijun Wang
  • Chun Han
Current Topics in Medicinal Chemistry (2023) 23 (21): 2048.
  • Andrew R. Conery
  • Jennifer L. Rocnik
  • Patrick Trojer
Nature Chemical Biology (2022) 18 (2): 124.
  • Aishat Motolani
  • Matthew Martin
  • Mengyao Sun
  • Tao Lu
Life (2021) 11 (10): 1074.
  • Dirk Brehmer
  • Lijs Beke
  • Tongfei Wu
  • Hillary J. Millar
  • Christopher Moy
  • Weimei Sun
  • Geert Mannens
  • Vineet Pande
  • An Boeckx
  • Erika van Heerde
  • Thomas Nys
  • Emmanuel M. Gustin
  • Bie Verbist
  • Longen Zhou
  • Yue Fan
  • Vipul Bhargava
  • Pegah Safabakhsh
  • Petra Vinken
  • Tinne Verhulst
  • Angelique Gilbert
  • Sumit Rai
  • Timothy A. Graubert
  • Friederike Pastore
  • Danilo Fiore
  • Junchen Gu
  • Amy Johnson
  • Ulrike Philippar
  • Barbara Morschhäuser
  • David Walker
  • Desiree De Lange
  • Vikki Keersmaekers
  • Marcel Viellevoye
  • Gaston Diels
  • Wim Schepens
  • Jan Willem Thuring
  • Lieven Meerpoel
  • Kathryn Packman
  • Matthew V. Lorenzi
  • Sylvie Laquerre
Molecular Cancer Therapeutics (2021) 20 (12): 2317.
  • Yingqing Chen
  • Xiaomin Shao
  • Xiangge Zhao
  • Yuan Ji
  • Xiaorong Liu
  • Peixuan Li
  • Mingyu Zhang
  • Qianqian Wang
Biomedicine & Pharmacotherapy (2021) 144: 112252.
Close Modal

or Create an Account

Close Modal
Close Modal